A Caltech Library Service

Comparison of the Interactions of Transferrin Receptor and Transferrin Receptor 2 with Transferrin and the Hereditary Hemochromatosis Protein HFE

West, Anthony P., Jr. and Bennett, Melanie J. and Sellers, Vera M. and Andrews, Nancy C. and Enns, Caroline A. and Bjorkman, Pamela J. (2000) Comparison of the Interactions of Transferrin Receptor and Transferrin Receptor 2 with Transferrin and the Hereditary Hemochromatosis Protein HFE. Journal of Biological Chemistry, 275 (49). pp. 38135-38138. ISSN 0021-9258. doi:10.1074/jbc.C000664200.

PDF - Published Version
See Usage Policy.


Use this Persistent URL to link to this item:


The transferrin receptor (TfR) interacts with two proteins important for iron metabolism, transferrin (Tf) and HFE, the protein mutated in hereditary hemochromatosis. A second receptor for Tf, TfR2, was recently identified and found to be functional for iron uptake in transfected cells (Kawabata, H., Germain, R. S., Vuong, P. T., Nakamaki, T., Said, J. W., and Koeffler, H. P. (2000) J. Biol. Chem. 275, 16618-16625). TfR2 has a pattern of expression and regulation that is distinct from TfR, and mutations in TfR2 have been recognized as the cause of a non-HFE linked form of hemochromatosis (Camaschella, C., Roetto, A., Cali, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A., and Gasparini, P. (2000) Nat. Genet. 25, 14-15). To investigate the relationship between TfR, TfR2, Tf, and HFE, we performed a series of binding experiments using soluble forms of these proteins. We find no detectable binding between TfR2 and HFE by co-immunoprecipitation or using a surface plasmon resonance-based assay. The affinity of TfR2 for iron-loaded Tf was determined to be 27 nM, 25-fold lower than the affinity of TfR for Tf. These results imply that HFE regulates Tf-mediated iron uptake only from the classical TfR and that TfR2 does not compete for HFE binding in cells expressing both forms of TfR.

Item Type:Article
Related URLs:
URLURL TypeDescription
Bjorkman, Pamela J.0000-0002-2277-3990
Additional Information:© 2000 by The American Society for Biochemistry and Molecular Biology, Inc. Received for publication, September 22, 2000 Published, JBC Papers in Press, October 10, 2000, DOI 10.1074/jbc.C000664200 [Accelerated Publication] We thank Dr. Peter Snow of the Caltech Protein Expression Facility for construction of recombinant baculovirus expressing TfR2 and Dr. Andrew Herr for help with biosensor analyses. This work was supported by the Howard Hughes Medical Institute (to P. J. B. and N. C. A.), Grant DRG-1445 from the Cancer Research Fund of the Damon Runyon-Walter Winchell Foundation Fellowship (to A. P. W.), and National Institutes of Health Grant DK 54488 (to C. A. E.).The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
Funding AgencyGrant Number
Howard Hughes Medical Institute (HHMI)UNSPECIFIED
Damon Runyon-Walter Winchell Foundation Cancer Research FundDRG-1445
NIHDK 54488
Issue or Number:49
Record Number:CaltechAUTHORS:WESjbc00
Persistent URL:
Usage Policy:No commercial reproduction, distribution, display or performance rights in this work are provided.
ID Code:6138
Deposited By: Archive Administrator
Deposited On:27 Nov 2006
Last Modified:08 Nov 2021 20:31

Repository Staff Only: item control page